Internet Searching May Get ‘Riskier’ For Patients After FDA Citations
This article was originally published in The Pink Sheet Daily
“Sponsored searches” need to contain risk information, agency tells 14 firms in letters covering 48 products.
You may also be interested in...
US FDA Once Again Dings Rx Drug Sponsored Link For Excluding Risk Information
Eton Pharmaceuticals gets untitled letter for promotion of its Alkindi Sprinkle hydrocortisone granules for treatment of pediatric adrenal insufficiency. The agency sent two letters last year objecting to sponsored links after a decade pause.
US FDA Actions On Rx Drug Promos Covered New Territory Last Year
Office of Prescription Drug Promotion issued just six letters citing companies for improper drug promotion in 2020, including the placement of safety information in an email and making unfounded COVID-19 claims. New research projects focus on celebrity endorsements, medical conference materials.
US FDA Aims For More Timely Reviews Of Rx Drug Launch Promotions
New review process planned to launch next year. FDA officials and industry reps note re-emergence of FDA enforcement actions targeting internet-sponsored links.